SavedAdd your journal

Journals / Uzmanlık Sonrası Eğitim ve Güncel Gelişmeler Dergisi / 2007 / Cilt: 4 - Sayı: 1

Periconceptional folic acid use among women living in Duzce region

Düzce yöresindeki gebelerde folik asit kullanımını etkileyen faktörler

Aslı SOMUNKIRAN
Efe Ayşe ARICAN
Oğuz YÜCEL
Pages
33–36
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: The lack of information is the main reason why folic acid is not used preconceptionally and in early pregnancy.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The objectives of this study were to determine the rate of periconceptional folic acid use among women living in Duzce region, to assess folic acid awareness and to examine the association between folic acid use and education level.
📊
Key Findings & Data:Methods: A questionnaire was administered to all pregnant women attending to our antenatal care clinic between December 2004 and February 2005.
💡
Conclusion & Impact:Conclusion: The lack of information is the main reason why folic acid is not used preconceptionally and in early pregnancy.
🔬Design:Survey & Empirical Study
📍Scope:2004 Verileri
⚙️Variables:Anketler · Folik asit · Gebelik

Abstract

The objectives of this study were to determine the rate of periconceptional folic acid use among women living in Duzce region, to assess folic acid awareness and to examine the association between folic acid use and education level. Methods: A questionnaire was administered to all pregnant women attending to our antenatal care clinic between December 2004 and February 2005. Results: One hundred and twenty eight women were interviewed during the study period. Seventy-five women (58.6%) planned their pregnancy. Of these women fourteen (10.9%) used folic acid supplements before conception. 78.6% of women who took folic acid before conception (11 women) were health workers. Conclusion: The lack of information is the main reason why folic acid is not used preconceptionally and in early pregnancy.

Özet

Düzce yöresinde yaşayan gebelerin gebelik öncesi folik asit kullanımı oranını, folik asitle ilgili bilgilerini ve bilgi düzeyi ile öğrenim durumu ilişkisini araştırmaktır. Metod: Aralık 2004-Şubat 2005 tarihleri arasında gebelik takibi için başvuran 128 sağlıklı gebeye folik asit ile ilgili bilgilerini ölçmek için özel olarak oluşturulan anket uygulandı. Bulgular: Anket uygulanan gebelerin % 58,6'sında (75 gebe) gebeliğin planlı olduğu görüldü. Bu gebelerden 14'ü (%10,9) folik asit kullanmaya gebelik öncesi başlamıştı. Folik asit kullanmaya gebelik öncesi başlayan hastaların %78.6'sının (11 gebe) sağlık çalışanı olduğu görüldü. Sonuç: Sonuçlarımız gebelik öncesi ve erken gebelikte folik asit kullanılmamasının temel nedeninin ilaç uyumu sorunu değil bilgi ve yönlendirme eksikliği olduğunu düşündürmektedir.

🔖

Cite This Article

SOMUNKIRAN, A., ARICAN, E. A., YÜCEL, O. (2007). Periconceptional folic acid use among women living in Duzce region. Uzmanlık Sonrası Eğitim ve Güncel Gelişmeler Dergisi, Cilt: 4 - Sayı: 1, 33–36. https://ajindex.com/articles/320611

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Botto LD, Moore CA, Khoury MJ, Erickson JD. Review article- Neural tube defects. N Engl J Med - Medical Progress 1999; 341: 1509-19
  2. Lumley J, Watson L, Watson M, Bower C. Periconceptional supplementation with folate and/or multivitamins for preventing neural tube defects. Cochrane Database Syst Rev 2000: CD001056
  3. Berry RJ, Li Z, Erickson JD et al. Prevention of neural-tube defects with folic acid in China. China-U.S. Collaborative Project for Neural Tube Defect Prevention. N Engl J Med 1999; 341:1485-90
  4. MRC Vitamin Study Research Group. Prevention of neural tube defects: Results of the Medical Research Council vitamin study. Lancet 1991; 338: 131-7
  5. Yüce MA, Candaş T, Sayın NC, Balkanlı-Kaplan P, Güçer F, Yardım T. Olgularımızda gebelik öncesi ve gebelikte folik asit kullanımı Türk Fertilite Dergisi 2001;9(3):251-7
  6. Aydınlı K, Çağdaş A, Kayserili H, Kuseyri F, Tükel T, Eriş H, Apak MY. Prekonsepsiyonel folik asit ve multivitamin tedavisinin nonsendromik nöral tüp defektlerinin yineleme riski üzerine etkisi Türkiye Klinikleri Jinekoloji-Obstetrik 1999;9(3):183-9
  7. Centers for Disease Control. Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. MMWR Recomm Rep 1992;41:1-7
  8. Van Allen MI, Fraser FC, Dallaire L, et al. Recommendations on the use of folic acid supplementation to prevent the recurrence of neural tube defects. Clinical Teratology Committee, Canadian College of Medical Geneticists. CMAJ 1993;149:1239-43
  9. Rasmussen LB, Andersen NL, Andersson G, et al. Folate and neural tube defects. Recommendations from a Danish working group. Dan Med Bull 1998;45:213-7
  10. Botto LD, Lisi A, Robert-Gnansia E, Erickson JD, Vollset SE, Mastroiacovo P, et.al. International retrospective cohort study of neural tube defects in relation to folic acid recommendations: are the recommendations working? BMJ 2005; 330(7491):571. doi:10.1136/bmj.38336.664352.82 11. Kondo A, Kamihira O, Shimosuka Y, Okai I, Gotoh M, Ozawa H. Awareness of the role of folic acid, dietary folate intake and plasma folate concentration in Japan. J Obstet GynaecolRes 2005;31:172-7
  11. Tunçbilek E. ve ark. Türkiye'de konjenital malformasyon sıklığı, dağılımı, risk faktörleri ve yenidoğanların antropometrik değerlendirmesi. TÜBİTAK Matbaası, Ankara 1996
  12. Unusan N. Assessment of Turkish women's knowledge concerning folic acid and prevention of birth defects. Public Health Nutr2004;7: 851-5
  13. Abdulrazz